Thapsigargin

N/A

Report date: 2022/09/28 20:01:03

Base Information

Drug NameThapsigargin
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Actionc-Jun N-terminal kinase modulatorsVoltage-gated calcium channel blockersP-glycoprotein 1 inhibitors +[4] 
TargetsP-glycoprotein 1Calcium-transporting ATPasesVoltage-gated calcium channel +[4] 
Therapy Area/IndicationsMyocardial IschemiaHeart FailureArrhythmias, Cardiac +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySingapore
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck & CoLC United Chemical Corp +[3] 
Active IndicationsN/A
Inactive IndicationsMyocardial IschemiaHeart FailureArrhythmias, Cardiac +[4] 

Other Information

ATC CodeN/A
Related LinksN/A